Publication date: Apr 12, 2019
In existence for nearly 25 years, the Healthcare Systems Research Network (HCSRN) is an established and sustainable network of health care systems that serves as a “real world” laboratory to enable the integration of research findings into practice. The objective of this paper is to demonstrate how the HCSRN serves as an ideal environment for studying dissemination and implementation of evidence-based practices into health care systems through the example of developing a multi-site study on the implementation of evidence-based precision medicine practices.
The “Implementing Universal Lynch Syndrome Screening (IMPULSS)” study (NIH R01CA211723) involves seven HCSRN health care systems and two external health care systems. The IMPULSS study will describe and explain organizational variability around Lynch syndrome (LS) screening to identify which factors in different organizational contexts are important for successful implementation of LS screening programs and will create a toolkit to facilitate organizational decision making around implementation and improvement of precision medicine programs in health care systems.
The strengths of the HCSRN that facilitate D&I research include: 1) a culture of collaboration, 2) standardization of data and processes across systems, and 3) researchers embedded in diverse health care systems. We describe how these strengths contributed to developing the IMPULSS study.
Given the importance of conducting research in real world settings to improve patient outcomes, the unique strengths of the HCSRN are of vital importance. The IMPULSS study is one case example of how the strengths of the HCSRN make it an excellent environment for research on implementing evidence-based precision medicine practices in health care systems.
Open Access PDF
Rahm, A.K., , Ladd, Burnett-Hartman, A.N., Epstein, M.M., Lowery, J.T., Lu, C.Y., Pawloski, P.A., Sharaf, R.N., Liang, S.Y., and Hunter, J.E. The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine. 04421. 2019 EGEMS (Wash DC) (7):1.
|Lynch Syndrome||Precision medicine|
|Precision Medicine||Health system|
- Trapelo Leaders Discuss Collaboration and the Role of Prior Authorization in Precision Medicine Today
- Precision medicine in colorectal cancer.
- Evotec And Indivumed Announce Strategic Drug Discovery Collaboration On Precision Medicine For Colorectal Cancer
- Geisinger, Intermountain Recognized for Precision Medicine Efforts
- A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine.